AMRX - Amneal gets approval for generic injectable on FDA's shortage list
2023-09-06 18:16:56 ET
More on Amneal Pharmaceuticals
- Seeking Alpha’s Quant Rating on Amneal Pharmaceuticals
- Historical earnings data for Amneal Pharmaceuticals
- Financial information for Amneal Pharmaceuticals
- Amneal Pharmaceuticals, Inc. 2023 Q2 - Results - Earnings Call Presentation
- Amneal Pharmaceuticals, Inc. ( AMRX ) Q2 2023 Earnings Call Transcript
- Amneal Pharmaceuticals Could Have An Upbeat Q2
- Generic drugs lobby sues Minnesota over price control law
- Biggest stock movers today: Pegasystems, Digital World Acquisition, MP Materials and more
- Amneal receives Complete Response Letter for Parkinson's candidate
- Amneal granted FDA nod for chemotherapy injection
For further details see:
Amneal gets approval for generic injectable on FDA's shortage list